China, Aug. 18 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the Therapeutic Effect of Igammod in the Treatment of Generalized Myasthenia Gravis'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130173
Registration Time: 2026/08/17
Type: Observational study
Primary Sponsor: The Affiliated Hospital of Xuzhou Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=336560
Published by HT Digital Content Services with permission from Health Daily Digest....